Development and in vitro permeation studies of proniosomal based transdermal delivery system of Atenolol.
暂无分享,去创建一个
[1] A. Ram,et al. NON-IONIC PROVESICULAR DRUG CARRIER: AN OVERVIEW , 2013 .
[2] Omar K. Shoukry,et al. Novel sugar esters proniosomes for transdermal delivery of vinpocetine: preclinical and clinical studies. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[3] A. ElMeshad,et al. Comparative Study on the Effects of Some Polyoxyethylene Alkyl Ether and Sorbitan Fatty Acid Ester Surfactants on the Performance of Transdermal Carvedilol Proniosomal Gel Using Experimental Design , 2010, AAPS PharmSciTech.
[4] K. Srikanth,et al. Proniosomes: A Novel Drug Carrier System , 2010 .
[5] V. Sankar,et al. Formulation and Optimization of Zidovudine Niosomes , 2010, AAPS PharmSciTech.
[6] V. Gajbhiye,et al. Enhanced Oral Bioavailability of Griseofulvin via Niosomes , 2009, AAPS PharmSciTech.
[7] Hatem Fessi,et al. Topical delivery of cosmetics and drugs. Molecular aspects of percutaneous absorption and delivery. , 2009, European journal of dermatology : EJD.
[8] M. Jug,et al. Novel cyclodextrin-based film formulation intended for buccal delivery of atenolol , 2009, Drug development and industrial pharmacy.
[9] M. Anwer,et al. Proniosomal transdermal therapeutic system of losartan potassium: development and pharmacokinetic evaluation , 2009, Journal of drug targeting.
[10] Ra,et al. Proniosome based drug delivery system of piroxicam , 2008 .
[11] O. Sammour,et al. Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes. , 2008, International journal of pharmaceutics.
[12] T. Baykara,et al. In vitro and in vivo transdermal studies of atenolol using iontophoresis. , 2008, Acta poloniae pharmaceutica.
[13] Biana Godin,et al. Transdermal skin delivery: predictions for humans from in vivo, ex vivo and animal models. , 2007, Advanced drug delivery reviews.
[14] Ankur Gupta,et al. Design and Development of a Proniosomal Transdermal Drug Delivery System for Captopril , 2007 .
[15] A. Fadda,et al. Niosomes as carriers for tretinoin. III. A study into the in vitro cutaneous delivery of vesicle-incorporated tretinoin. , 2006, International journal of pharmaceutics.
[16] Sang-Chul Shin,et al. Enhanced bioavailability of atenolol by transdermal administration of the ethylene-vinyl acetate matrix in rabbits. , 2003, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[17] R. Umamaheswari,et al. Protransfersomes For Effective Transdermal Delivery Of Norgestrel Preparation And In Vitro Characterization , 2003 .
[18] A. Fadda,et al. Niosomes as carriers for tretinoin. I. Preparation and properties. , 2002, International journal of pharmaceutics.
[19] J. Fang,et al. In vitro skin permeation of estradiol from various proniosome formulations. , 2001, International journal of pharmaceutics.
[20] N. Udupa,et al. Formulation and Evaluation Of Nimesulide Transdermal Drug Delivery Systems , 2000 .
[21] D. Rhodes,et al. Proniosomes: a novel drug carrier preparation. , 1999, International journal of pharmaceutics.
[22] Ijeoma F. Uchegbu,et al. Non-ionic surfactant based vesicles (niosomes) in drug delivery , 1998 .
[23] Ramesh. Transdermal delivery of drugs , 1997 .
[24] Indra K. Reddy,et al. Atenolol gastrointestinal therapeutic system: optimization of formulation variables using response surface methodology , 1997 .
[25] R. J. Harwood. Transdermal delivery of drugs , 1988 .
[26] R. Shanks,et al. Clinical pharmacologic observations on atenolol, a beta‐adrenoceptor blocker , 1976, Clinical pharmacology and therapeutics.